Derleme
BibTex RIS Kaynak Göster

Obezite ve Gebelik

Yıl 2018, Cilt: 2 Sayı: 3, 101 - 106, 28.12.2018

Gülhan Duman Fahri Bayram

Öz

Doğurganlık çağındaki kadınların %50’si fazla kilolu [vücut
kitle indeksi (VKI): 24.9-29.9kg/m²] ya da obezdir (BMI>30 kg/m²), %18’i
gebeliğe başlarken obezdir. Amerika Birleşik Devletleri ve Avrupa’da %20-40
kadın gebelik sırasında önerilenden fazla kilo almaktadır, bu ise maternal ve
fetal komplikasyonların artışı ile sonuçlanmaktadır. Gebelik, doğum ve doğum
sonrasında ölen kadınların yarıdan fazlası kilolu ya da obezdir.  Obezitenin ciddi problem olduğu günümüzde gebeliğe obez başlayan veya gebelik sırasında fazla kilo alan gebelerin yönetimi hem anne hem fetüs sağlığı için önemlidir. özellikle sağlıksız bir mikroçevreye maruz kalan fetüste ileride de ciddi metabolik problemler gelişmektedir. 

Anahtar Kelimeler

obezite gebelik

Kaynakça

  • 1- Thangaratinam S, Rogozińska E, Jolly K, Glinkowski S, Duda W, Borowiack E, Khan K. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technology Assessment. 2012; 16(31):1366-5278.
  • 2- Davies GA. L, Maxwell C, McLeod L. Obesity in Pregnancy, SOGC Clinical Practice Guideline. JOGC. 2010; 209:165-73.
  • 3- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health Karger.2013; 34: 1-7.
  • 4- Hajagos-Tóth J, Ducza E, Samavati R, Vari S.G, Gaspar R. Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility. Croatian Medical Journal. 2017; 58(2), 96-104.
  • 5- Lashen H, Fear K, Sturdee DW, Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004; 19: 1644-1646.
  • 6- Abdollahi M, Cushman M, Rosendaal FR, Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003; 89: 493-498.
  • 7- Yogev Y, Catalano PM. Pregnancy and Obesity. Obstet Gynecol Clin N Am. 2009;36: 285-300.
  • 8- Davies GA, Maxwell C, McLeod L. SOGC Clinical Practice Guidelines: Obesity in pregnancy. Int J Gynaecol Obstet. 2010; 110:1673- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health. Karger.2013; 34 :1-7.
  • 9- Caughey AB, Stotland NE, Washington AE, Escobar GJ. Who is at risk for prolonged and postterm pregnancy? Am J Obstet Gynecol. 2009;200: 683-5.10- American College of Obstetricans and Gynecologists Committee on Obstetric Practice. 2013; 549.
  • 11- James A. Committee on Practice Bulletins-Obstetrics. Tromboembolism in pregnancy. Obstet Gynecol. 2011;118:718.
  • 12- IOM (Institute of Medicine) and NRC (National ResearchCouncil). Weight Gain During Pregnancy:Reexamining the Guidelines. The National Academies Pres. Washington, DC; 2009.
  • 13- The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008; 89: 505-522.
  • 14- Jain A. P, Gavard J. A, Rice J. J, Catanzaro R. B, Artal R, Hopkins S. A. The Impact of Interpregnancy Weight Change on Birthweight in Obese Women. Obstetrical & Gynecological Survey. 2013; 68(6): 409-411.
  • 15- Glazer N. L, Hendrickson A. F, Schellenbaum G. D, Mueller B. A. Weight Change and the Risk of Gestational Diabetes in Obese Women. Epidemiology. 2004; 15(6): 733-737.
  • 16- American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017; 40 (Supplement 1):11-24.
  • 17- Clinical practice guidelines for healthy eating for the preventıon and treatment of metabolic and endocrine diseases in adults:cosponsored by the Amerıcan Association of clinical endocrinologists/ the American College of Endocrınology. Endocrine Practice. 2013;19 (Suppl 3).
  • 18- Harborne L, Sattar N, Norman J.E, Fleming, R. Metformin and weight loss in obese womenwith polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab. 2005; 90: 4593-8.
  • 19- Li Z, Magione M, Tu W, et al (RAND Health Division, Santa Monica, Calif; Greater Los Angeles VA Healthcare System; Dept of Veterans Affairs, Cincinnati, Ohio). Meta - analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005; 142: 532-46.
  • 20- Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and Surgical Management of Obesity in Primary Care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142: 525-31.

Yıl 2018, Cilt: 2 Sayı: 3, 101 - 106, 28.12.2018

Gülhan Duman Fahri Bayram

Öz

Kaynakça

  • 1- Thangaratinam S, Rogozińska E, Jolly K, Glinkowski S, Duda W, Borowiack E, Khan K. Interventions to reduce or prevent obesity in pregnant women: a systematic review. Health Technology Assessment. 2012; 16(31):1366-5278.
  • 2- Davies GA. L, Maxwell C, McLeod L. Obesity in Pregnancy, SOGC Clinical Practice Guideline. JOGC. 2010; 209:165-73.
  • 3- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health Karger.2013; 34: 1-7.
  • 4- Hajagos-Tóth J, Ducza E, Samavati R, Vari S.G, Gaspar R. Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility. Croatian Medical Journal. 2017; 58(2), 96-104.
  • 5- Lashen H, Fear K, Sturdee DW, Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod. 2004; 19: 1644-1646.
  • 6- Abdollahi M, Cushman M, Rosendaal FR, Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003; 89: 493-498.
  • 7- Yogev Y, Catalano PM. Pregnancy and Obesity. Obstet Gynecol Clin N Am. 2009;36: 285-300.
  • 8- Davies GA, Maxwell C, McLeod L. SOGC Clinical Practice Guidelines: Obesity in pregnancy. Int J Gynaecol Obstet. 2010; 110:1673- Tenenbaum,- Gavish K, Hod M. Fetal Diagnosis and Therapy: Impact of maternal obesity on fetal health. Karger.2013; 34 :1-7.
  • 9- Caughey AB, Stotland NE, Washington AE, Escobar GJ. Who is at risk for prolonged and postterm pregnancy? Am J Obstet Gynecol. 2009;200: 683-5.10- American College of Obstetricans and Gynecologists Committee on Obstetric Practice. 2013; 549.
  • 11- James A. Committee on Practice Bulletins-Obstetrics. Tromboembolism in pregnancy. Obstet Gynecol. 2011;118:718.
  • 12- IOM (Institute of Medicine) and NRC (National ResearchCouncil). Weight Gain During Pregnancy:Reexamining the Guidelines. The National Academies Pres. Washington, DC; 2009.
  • 13- The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008; 89: 505-522.
  • 14- Jain A. P, Gavard J. A, Rice J. J, Catanzaro R. B, Artal R, Hopkins S. A. The Impact of Interpregnancy Weight Change on Birthweight in Obese Women. Obstetrical & Gynecological Survey. 2013; 68(6): 409-411.
  • 15- Glazer N. L, Hendrickson A. F, Schellenbaum G. D, Mueller B. A. Weight Change and the Risk of Gestational Diabetes in Obese Women. Epidemiology. 2004; 15(6): 733-737.
  • 16- American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2017; 40 (Supplement 1):11-24.
  • 17- Clinical practice guidelines for healthy eating for the preventıon and treatment of metabolic and endocrine diseases in adults:cosponsored by the Amerıcan Association of clinical endocrinologists/ the American College of Endocrınology. Endocrine Practice. 2013;19 (Suppl 3).
  • 18- Harborne L, Sattar N, Norman J.E, Fleming, R. Metformin and weight loss in obese womenwith polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab. 2005; 90: 4593-8.
  • 19- Li Z, Magione M, Tu W, et al (RAND Health Division, Santa Monica, Calif; Greater Los Angeles VA Healthcare System; Dept of Veterans Affairs, Cincinnati, Ohio). Meta - analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005; 142: 532-46.
  • 20- Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and Surgical Management of Obesity in Primary Care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142: 525-31.
Toplam 19 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Derleme
Yazarlar

Gülhan Duman

Fahri Bayram

Yayımlanma Tarihi 28 Aralık 2018
Kabul Tarihi 28 Aralık 2018
Yayımlandığı Sayı Yıl 2018 Cilt: 2 Sayı: 3

Kaynak Göster

APA Duman, G., & Bayram, F. (2018). Obezite ve Gebelik. Türkiye Diyabet Ve Obezite Dergisi, 2(3), 101-106.
AMA Duman G, Bayram F. Obezite ve Gebelik. Turk J Diab Obes. Aralık 2018;2(3):101-106.
Chicago Duman, Gülhan, ve Fahri Bayram. “Obezite Ve Gebelik”. Türkiye Diyabet Ve Obezite Dergisi 2, sy. 3 (Aralık 2018): 101-6.
EndNote Duman G, Bayram F (01 Aralık 2018) Obezite ve Gebelik. Türkiye Diyabet ve Obezite Dergisi 2 3 101–106.
IEEE G. Duman ve F. Bayram, “Obezite ve Gebelik”, Turk J Diab Obes, c. 2, sy. 3, ss. 101–106, 2018.
ISNAD Duman, Gülhan - Bayram, Fahri. “Obezite Ve Gebelik”. Türkiye Diyabet ve Obezite Dergisi 2/3 (Aralık 2018), 101-106.
JAMA Duman G, Bayram F. Obezite ve Gebelik. Turk J Diab Obes. 2018;2:101–106.
MLA Duman, Gülhan ve Fahri Bayram. “Obezite Ve Gebelik”. Türkiye Diyabet Ve Obezite Dergisi, c. 2, sy. 3, 2018, ss. 101-6.
Vancouver Duman G, Bayram F. Obezite ve Gebelik. Turk J Diab Obes. 2018;2(3):101-6.
 Kapak Resmi İndir

Zonguldak Bülent Ecevit Üniversitesi Obezite ve Diyabet Uygulama ve Araştırma Merkezi’nin bilimsel yayım organıdır.

Web: https://obdm.beun.edu.tr/  Twitter: https://twitter.com/obezite_diyabet     Instagram: https://www.instagram.com/zbeuobezitediyabet/